Apelin‐13 Attenuates Blood–Brain Barrier Dysfunction Following Intracerebral Hemorrhage via Targeting the Keap1/Nrf2 Signaling
In conclusion, these findings demonstrate that through its engagement with APJ, Apelin-13 activates the endothelial Keap1/Nrf2 pathway to protect against ICH-induced BBB disruption and facilitate neurological recovery, highlighting its therapeutic promise for ICH.
Authors
- Juanfeng Qian
- Mengzhou Xue
- Lingxiao Qi
- Pingping Guo
- Rabeea Siddique
- V. Wee Yong
Institutions
- Allen Institute for Brain Science (US)
- University of Calgary (CA)
- Zhengzhou University (CN)
- Henan Academy of Sciences (CN)
- Second Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cns.70706
- Citations
- 1
- Primary Topic
- Apelin-related biomedical research
- Type
- article
- Field-Weighted Citation Impact
- 1.39